Trifluoromethanesulfonic Acid

Trifluoromethanesulfonic Acid

SCHEMBL7682358

CCOCC.O=S(=O)(O)C(F)(F)F

nearest known ligand 0.35

Full drug profile on Sugi Atlas →

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
EPHX1 P07099 1/20 0.34
FAAH O00519 4/20 0.31
CES2 O00748 2/20 0.31
CES1 P23141 1/20 0.31
F2 P00734 1/20 0.31
PRSS1 P07477 1/20 0.31
PRSS2 P07478 1/20 0.31
PRSS3 P35030 1/20 0.31
TSHR P16473 1/20 0.31
CA1 P00915 3/20 0.31
CA2 P00918 3/20 0.31
CA7 P43166 1/20 0.30
CA13 Q8N1Q1 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoromethanesulfonic Acid SCHEMBL3222183 0.84 ALDH1A1 (0.58) ALDH1A1TSHR
Trifluoromethanesulfonic Acid SCHEMBL2285727 0.83 ALDH1A1 (0.41) ALDH1A1L3MBTL1EPHX1FAAHCES2
Trifluoromethanesulfonic Acid SCHEMBL27910342 0.80 ALDH1A1 (0.39) ALDH1A1L3MBTL1EPHX1FAAHCES2
Ether SCHEMBL11160700 0.80 TSHR (0.50) ALDH1A1FAAHTSHRCA1CA2
Trifluoromethanesulfonic Acid SCHEMBL1851236 0.80 ALDH1A1 (0.39) ALDH1A1L3MBTL1EPHX1FAAHCES2
Trifluoromethanesulfonic Acid SCHEMBL3361058 0.80 EPHX1 (0.43) ALDH1A1L3MBTL1EPHX1FAAHCES2
Trifluoromethanesulfonic Acid SCHEMBL27669034 0.80 ALDH1A1 (0.39) ALDH1A1L3MBTL1EPHX1FAAHCES2
Trifluoromethanesulfonic Acid SCHEMBL27876172 0.80 EPHX1 (0.36) ALDH1A1L3MBTL1EPHX1FAAHCES2
Trifluoromethanesulfonic Acid SCHEMBL6192996 0.80 CA1 (0.39) ALDH1A1L3MBTL1EPHX1TSHRCA1
Ether SCHEMBL27570944 0.80 CA5A (0.43) ALDH1A1TSHRCA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115698002-A Compositions and methods for parasite control 菲利普莫里斯生产公司 2023-02-03 CN disclosed
CN-110092712-B Preparation method of bisphenol A 三峡大学 2022-07-01 CN disclosed
US-6489354-B1 IN PARTICULAR, THESE COMPOUNDS ARE USEFUL AS MODULATORS OF THE CHEMOKINE RECEPTORS CCR-3 AND/OR CCR-5 USEFUL IN THE TREATMENT AND PREVENTION OF ATOPIC CONDITIONS INCLUDING ALLERGIC RHINITIS, DERMATITIS, CONJUNCTIVITIS, AND ASTHMA MERCK & CO., INC. 2002-12-03 US disclosed
US-6362201-B1 ANTIINFLAMMATORY AGENTS; ANTIALLERGENS MERCK & CO., INC. 2002-03-26 US disclosed
US-6303593-B1 FOR THERAPY HUMAN IMMUNODEFICIENCY VIRUS INFECTION, AQUIRED IMMUNODEFICIENCY SYNDROME (AIDS), INFLAMMATORY AND IMMUNOREGULATORY DISORDER OR DISEASE, ASTHMA, ALLERGIC RHINITIS, DERMATITIS, CONJUNCTIVITIS, ATHEROSCLEROSIS MERCK & CO., INC. 2001-10-16 US disclosed
WO-2000051608-A1 3-THIENYL AND 3-FURANYL PYRROLIDINE MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY MERCK & CO., INC. (US) 2000-09-08 WO disclosed
WO-2000051607-A1 3-CYCLOPROPYL AND 3-CYCLOBUTYL PYRROLIDINE MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY MERCK & CO., INC. (US) 2000-09-08 WO disclosed
WO-2000051610-A1 PYRROLIDINE MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY MERCK & CO., INC. (US) 2000-09-08 WO disclosed
WO-2000051609-A1 3-ALKYL SUBSTITUTED PYRROLIDINE MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY MERCK & CO., INC. (US) 2000-09-08 WO disclosed